BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34898635)

  • 1. Diagnostic value of symptoms for pediatric SARS-CoV-2 infection in a primary care setting.
    Weng CH; Butt WWW; Brooks MB; Clarke C; Jenkins HE; Holland SD; Chiang SS
    PLoS One; 2021; 16(12):e0249980. PubMed ID: 34898635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
    Elliott J; Whitaker M; Bodinier B; Eales O; Riley S; Ward H; Cooke G; Darzi A; Chadeau-Hyam M; Elliott P
    PLoS Med; 2021 Sep; 18(9):e1003777. PubMed ID: 34582457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection in children and adolescents: a Brazilian experience.
    Santos AORD; Lucarevschi BR; Bajerl MH; Pires LO; Ubriaco DC; Nascimento LFC
    Rev Paul Pediatr; 2022; 40():e2021172. PubMed ID: 35544908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    medRxiv; 2020 Oct; ():. PubMed ID: 33106813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
    Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
    J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta.
    King JA; Whitten TA; Bakal JA; McAlister FA
    CMAJ; 2021 Jan; 193(1):E1-E9. PubMed ID: 33234533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and natural history of the first 2073 suspected COVID-19 cases in the Corona São Caetano primary care programme: a prospective cohort study.
    Leal FE; Mendes-Correa MC; Buss LF; Costa SF; Bizario JCS; de Souza SRP; Thomaz O; Tozetto-Mendoza TR; Villas-Boas LS; de Oliveira-da Silva LC; Grespan RMZ; Capuani L; Buccheri R; Domingues H; Alexander N; Mayaud P; Sabino EC
    BMJ Open; 2021 Jan; 11(1):e042745. PubMed ID: 33436471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results.
    Lan FY; Filler R; Mathew S; Buley J; Iliaki E; Bruno-Murtha LA; Osgood R; Christophi CA; Fernandez-Montero A; Kales SN
    PLoS One; 2020; 15(6):e0235460. PubMed ID: 32589687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System.
    Malden DE; Tartof SY; Ackerson BK; Hong V; Skarbinski J; Yau V; Qian L; Fischer H; Shaw SF; Caparosa S; Xie F
    JMIR Public Health Surveill; 2022 Dec; 8(12):e41529. PubMed ID: 36446133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
    Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
    Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical decision support tool for diagnosis of COVID-19 in hospitals.
    Saegerman C; Gilbert A; Donneau AF; Gangolf M; Diep AN; Meex C; Bontems S; Hayette MP; D'Orio V; Ghuysen A
    PLoS One; 2021; 16(3):e0247773. PubMed ID: 33705435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.
    Feehan AK; Fort D; Velasco C; Burton JH; Garcia-Diaz J; Price-Haywood EG; Sapp E; Pevey D; Seoane L
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e9-633.e16. PubMed ID: 33421576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
    Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
    Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts.
    Houston H; Hakki S; Pillay TD; Madon K; Derqui-Fernandez N; Koycheva A; Singanayagam A; Fenn J; Kundu R; Conibear E; Varro R; Cutajar J; Quinn V; Wang L; Narean JS; Tolosa-Wright MR; Barnett J; Kon OM; Tedder R; Taylor G; Zambon M; Ferguson N; Dunning J; Deeks JJ; Lalvani A
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34824057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
    Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
    JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of Isolated Symptoms for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children Tested During Peak Circulation of the Delta Variant.
    Westbrook AL; Benedit LC; Frediani JK; Griffiths MA; Khan NY; Levy JM; Morris CR; Rostad CA; Stone CL; Sullivan J; Vos MB; Welsh J; Wood A; Martin GS; Lam W; Pollock NR
    Clin Infect Dis; 2022 Sep; 75(7):1131-1139. PubMed ID: 35271694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.